[m j b]

OK, I looked it up. Surprised that Larry hasn't chimed in (he must be busy).

Apparently the FDA has delayed the final review results on HRTX's new drug for 3 months, until June. That doesn't mean that they won't approve it or that they're having trouble or really anything else than they need more time. For all we know, the project manager is out on maternity leave.

So the stock took a little dip after hours.

I suggest watching it and looking for a good entry point.

Of course, before doing that you should review this thread for my past suggestions and note that I am almost always very consistently wrong.